Shangya Technology Co (ROCO:6130) Total Liabilities : NT$164.6 Mil (As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Shangya Technology Co Total Liabilities?

Shangya Technology Co's Total Liabilities for the quarter that ended in Mar. 2024 was NT$164.6 Mil.

Shangya Technology Co's quarterly Total Liabilities declined from Sep. 2023 (NT$178.90 Mil) to Dec. 2023 (NT$166.47 Mil) and declined from Dec. 2023 (NT$166.47 Mil) to Mar. 2024 (NT$164.63 Mil).

Shangya Technology Co's annual Total Liabilities increased from Dec. 2021 (NT$77.98 Mil) to Dec. 2022 (NT$168.20 Mil) but then declined from Dec. 2022 (NT$168.20 Mil) to Dec. 2023 (NT$166.47 Mil).

Shangya Technology Co Total Liabilities Historical Data

The historical data trend for Shangya Technology Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shangya Technology Co Total Liabilities Chart

Shangya Technology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

233.65

788.89

77.98

168.20

166.47

Shangya Technology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															211.15	194.06	178.90	166.47	164.63

Shangya Technology Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Shangya Technology Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	71.04	+	(88.592	+	6.838
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	166.5

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	966.904	-	800.434
	=	166.5

Shangya Technology Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	71.088	+	(86.41	+	7.133
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	164.6

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	960.313	-	795.682
	=	164.6

Shangya Technology Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Shangya Technology Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Shangya Technology Co (ROCO:6130) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shangya Technology Co Ltd (ROCO:6130) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Nanjing East Road, 9th Floor - 12, No. 188, Section 5, Songshan District, Taipei, TWN, 10571

Website

https://www.singbao.com

Shangya Technology Co Ltd Formerly Singbao International Co Ltd is a Taiwan-based company involved in various activities of research and development. The Company's main business activities include research, development, production, and sales of wireless communication integrated circuits, satellite positioning system integrated circuits, and portable product ICs. The company segments are divided into the pharmaceutical business department, the product department, and others. The company derives the majority of its revenue from the pharmaceutical business department. which is responsible for the sales of Western medicines.

Shangya Technology Co (ROCO:6130) Headlines

No Headlines